glp-1 rekulo GLP-1R signalling promotes β-cell glucose metabolism via mTOR-dependent GLP-ONE + Receptor Activator
Description
Retatrutide targets three receptors (GLP-1 + GIP + glucagon) and achieved 24.2% mean weight loss at 48 weeks in Phase 2

Keep a record of any gastrointestinal symptoms, such as nausea, vomiting, or constipation, using a 010 scale

doi: 10.4093/dmj.2016.40.2.99 18 BunckMCDiamantMCornerAEliassonBMalloyJLShaginianRMet al

[DOI] [PMC free article] [PubMed] [Google Scholar] 64.Sharma S, Mells JE, Fu PP, Saxena NK, Anania FA

Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study

Keep a simple log if you need to track which site you used last
